News & Reports

Have some news you want to share with the Oregon Bio community?  Fill out our submission form.

Sparrow Pharmaceuticals has opened a $20M Series A preferred equity round

Based on recent information, Sparrow will now develop SPI-62, our best-in-class, proprietary HSD-1 inhibitor, as a new treatment for endogenous Cushing’s syndrome. We’re quite excited by the synergies of that new opportunity with our existing programs that could result in two (or more) new proprietary products without additional financing beyond Series A.

March 26, 2020 |

Washington Governor Jay Inslee issued a “Stay Home – Stay Healthy” Order

Washington Governor Jay Inslee issued a “Stay Home – Stay Healthy” Order on Monday, March 23, 2020. By this Proclamation 20-25, Proclamation 20-05 and all amendments to it remain in effect as otherwise amended and Proclamations 20-05, 20-07, 20-11, 20-13, and 20-14 are amended and superseded by this Proclamation (20-25) to impose a Stay Home – Stay Healthy Order throughout Washington State, which prohibits all people in Washington State from leaving their homes or participating in social, spiritual and […]

Oregon Trade Associations Team up on #COVID-19 Response

Major trade organizations Oregon Bioscience Association, Pacific Northwest Defense Coalition, Oregon Manufacturing Extension Partnership and Built Oregon are working together to establish a resource platform to identify, support and discover availability of care supplies and inventory for research and testing needs to address the unprecedented health pandemic COVID-19 (“Coronavirus”). An immediate survey – COVID-19: Supply and Equipment Inventory in Oregon

March 25, 2020 |

Oregon Bio on COVID-19: 11 Tips to manage and mitigate small business impact

During this time of significant disruption to local bio businesses, firms and organizations, as well as the potential global effects that are sure to be felt at all levels, Oregon Bio has researched some helpful resources and asked a few experts about short-term support to help small businesses mitigate and manage through this worldwide pandemic.

March 24, 2020 |

What Governor Brown’s “Stay Home, Stay Healthy” order means for bioscience in Oregon

On March 23, Governor Brown issued Executive Order No. 20-12 expanding on her previous restrictions on business operations. We are thankful for the work Gov. Brown and the legislature are doing to prevent the spread of the coronavirus.  If Gov. Brown decides it is necessary to expand upon this Executive Order, we will continue to advocate for the adoption of the federal DHS/CISA list of Essential Businesses as part of any additional “Stay Home/Shelter in Place” order.  The current order lists additional […]

Voice of Academia: The Making of a Scientist, Part 2

In the last issue, we introduced you to Carlos Crespo, Dr.PH, a doctor of Public Health with Portland State University. He’s using his own cultural background to build a new approach to cultivating diversity in new scientists/researchers.

Dr. Crespo and colleagues spearheaded a 10-year NIH grant to expose emerging college students to the fields of biomedical research. His grant application arrived at NIH (National Institutes of Health) at a time when NIH wanted to examine how to […]

February 28, 2020 |

Beaverton’s HTC completes Inventor Space Feasibility Study: Part 2

The Health Technology Collaborative recently completed its charge from Business Oregon, via a grant in the High Impact Opportunity Program (HIOP).  The results of the feasibility study dovetail well with the mission of the Health Technology Collaborative, which is to accelerate the growth of health technology in Oregon by providing innovators with sector-specific prototyping technology and access to a community of experts.

The $148,000 HIOP support was granted to the HTC in January, 2019, to examine the feasibility of […]

In 2019, Edwards Lifesciences presented data showing that patients undergoing less-invasive, transcatheter aortic valve replacement procedures performed better after one year compared to those who had [...]

Gov. Gretchen Whitmer (D-Mich.) said Sunday that bidding between states for personal protective equipment (PPE) is creating problems as hospitals across the country are seeing depleted supplies amid t [...]

Louisiana Gov. John Bel Edwards (D) said Sunday that the state's health care system could become overwhelmed by early April.Edwards told ABC's "This Week" that coronavirus cases ar [...]

Amid Amgen's pricing war with Sanofi and Regeneron's Praluent, PCSK9 cholesterol fighter Repatha has been looking for a leg up in a wide-ranging clinical program involving dozens of trials. [...]

Pregnant women in New York City will not have to endure labor alone or remain isolated from their partners and families after Gov. Andrew Cuomo (D) announced an executive order on Saturday."In no [...]

AstraZeneca's SGLT2 diabetes med Farxiga is chugging ahead to a pioneering FDA approval in heart failure patents with or without Type 2 diabetes--a first in its class. As it awaits that nod, Farx [...]

After teasing positive top-line results last November, a deeper dive into Merck & Co. and Bayer's heart failure drug vericiguat helped kick off this year's scientific meeting of the Amer [...]

Sanofi is joining the array of companies pursuing a COVID-19 vaccine based on messenger RNA (mRNA), an experimental genetic technology intended to coax the body's cells into producing proteins th [...]